Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The clinical-stage biotech said H1 2026 revenue fell to €1.1 million from €2.4 million a year earlier. It also said cash and cash equivalents were €17.1 million at June 30 and runway was estimated to December 2026.
Regulatory News:MaaT Pharma (EURONEXT:MAAT — the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today announced its half-year financial r…